XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway
暂无分享,去创建一个
M. Ferrari | D. Iliopoulos | Myles A Brown | X. Liu | W. Tam | Jenny C. Chang | Yiwen Chen | M. Greenblatt | L. Glimcher | M. Ni | D. Hu | M. Hatziapostolou | E. Lim | Chen Tan | Haifa Shen | J. Mai | Xi Chen | Qing Zhang | Q. Tang | S. Adoro | Bella Hu | Minkyung Song | M. Landis | Sandra J Shin | Myles A. Brown | S. Shin | Mauro Ferrari | X. Liu | X. Liu | Sandra J Shin
[1] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[2] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[3] S. Bicciato,et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors , 2012, Nature.
[4] Q. Sun,et al. CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma , 2012, Journal of experimental & clinical cancer research : CR.
[5] M. Manjili,et al. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. , 2012, Human pathology.
[6] M. Wicha,et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia , 2012, Proceedings of the National Academy of Sciences.
[7] J. Ingels,et al. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer , 2012, Breast Cancer Research.
[8] P. Walter,et al. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.
[9] Qian Wang,et al. A comprehensive view of nuclear receptor cancer cistromes. , 2011, Cancer research.
[10] T. Alain,et al. Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death. , 2011, Cancer cell.
[11] Kwok-Kin Wong,et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. , 2011, Cancer cell.
[12] Peter J. Bickel,et al. Measuring reproducibility of high-throughput experiments , 2011, 1110.4705.
[13] Mithat Gönen,et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.
[14] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[15] K. Struhl,et al. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.
[16] Lajos Pusztai,et al. A clinically relevant gene signature in triple negative and basal-like breast cancer , 2010, Breast Cancer Research.
[17] L. Carey,et al. Triple-negative breast cancer: disease entity or title of convenience? , 2010, Nature Reviews Clinical Oncology.
[18] A. Kazlauskas. Faculty Opinions recommendation of An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. , 2010 .
[19] A. Koong,et al. Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. , 2010, Cancer research.
[20] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[21] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[22] Debra L Winkeljohn. Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.
[23] B. Wouters,et al. Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.
[24] N. D. Clarke,et al. Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.
[25] Kou-Juey Wu,et al. Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.
[26] A. Protopopov,et al. The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis , 2007, Cancer cell.
[27] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[28] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[29] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[30] K. Mori,et al. XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.
[31] G. A. Barnard,et al. THE MEANING OF A SIGNIFICANCE LEVEL , 1947 .
[32] G. Barnard. Significance tests for 2 X 2 tables. , 1947, Biometrika.
[33] G. Barnard,et al. A New Test for 2 × 2 Tables , 1945 .
[34] G. Barnard,et al. A New Test for 2 × 2 Tables , 1945, Nature.